SCALE IBT: When combined with intensive behavioral therapy, liraglutide 3.0 mg produced 7.5% mean weight loss versus 4.0% with behavioral therapy plus placebo
High-purity research compound supplied by Pharma-One for controlled laboratory and analytical research applications where cellular energy transport and metabolic pathway investigation are required
Tirzepatide, in particular, has shown impressive results in clinical trials, with participants losing up to 22.5% of their body weight over 72 weeks
J Am Geriatr Soc 65(9):19881995 Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N et al (2020) Bimagrumab vs optimized standard of care for treatment of sarcopenia in Community-Dwelling older adults: A randomized clinical trial
Because of this targeted transport mechanism, ALCAR is not just a metabolic supplement